Login to Your Account

Pharma: Other News To Note

Tuesday, November 6, 2012
• Ferring Pharmaceuticals SA, of Saint Prex, Switzerland, said it received confirmation from European health authorities that its marketing authorization application for its controlled release, removable misoprostol vaginal delivery system (MVDS) has been accepted for review under the decentralized procedure.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription